Enhancing Palliative Care in ICU
Charite University, Berlin, Germany
2,040 participants
Oct 10, 2024
INTERVENTIONAL
Conditions
Summary
The aim of this study is to reduce the suffering in intensive care through palliative care consultations.
Eligibility
Inclusion Criteria10
- Patients:
- Patients in ICU who can give consent and those who can not (via their authorized representative or legal guardian, also possible with delayed consent)
- From 18 years
- The leading cause of critical illness is not cancer
- New admission on the participating ICU > 72h
- Assessment of the need for palliative care by the in-charge physi-cian of the ICU, because (1) there is a significant disagreement about ICU treatment or (2) because the physician considers ther-apy limitations for the patient or (3) the physician considers a benefit from specialized PC consultation for ICU physician, nurse, or patient or family.
- \- At least one relative(s) of a patient. This may or may not be the legal representative, depending on national legislation.
- Employed on the ITS as a doctor/nurse
- Employed in the clinical center as a member of the palliative care consultation service
- Exclusion criterion Refusal to participate
Exclusion Criteria6
- \- Patient is moribund and is expected to die within the next 24h
- Study cohort relatives:
- Refusal by the relative
- Refusal of the patient to participate in the intervention study
- <18 years of age
- Cohort of employees:
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A complex intervention is carried out in the intensive care unit. This includes: * telemedical consultations by specialized palliative care experts from external institutions for the respective hospital staff * the training of hospital staff in the intensive care unit in basic palliative care and * the use of checklists for the early identification of eligible patients and the structured recording of palliative care needs. The efficacy and cost-effectiveness of the complex intervention will be investigated using a controlled clinical trial in a cluster-randomized controlled design. In addition, as part of the multicenter clinical study in WP 2 staff, patients and relatives will also be surveyed.
No complex intervention is established, just routine procedures.
Locations(31)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06605079